110 related articles for article (PubMed ID: 15577317)
1. Chromosomal abnormalities, p53 and Bcl-2 expression and clinical outcome in choroidal melanoma.
Erol N; Oner U; Artan S; Işiksoy S; Yurdakul S
Melanoma Res; 2004 Dec; 14(6):473-8. PubMed ID: 15577317
[TBL] [Abstract][Full Text] [Related]
2. c-myc, p53, and Bcl-2 expression and clinical outcome in uveal melanoma.
Chana JS; Wilson GD; Cree IA; Alexander RA; Myatt N; Neale M; Foss AJ; Hungerford JL
Br J Ophthalmol; 1999 Jan; 83(1):110-4. PubMed ID: 10209447
[TBL] [Abstract][Full Text] [Related]
3. Clinical and cytogenetic analyses in uveal melanoma.
Kilic E; van Gils W; Lodder E; Beverloo HB; van Til ME; Mooy CM; Paridaens D; de Klein A; Luyten GP
Invest Ophthalmol Vis Sci; 2006 Sep; 47(9):3703-7. PubMed ID: 16936076
[TBL] [Abstract][Full Text] [Related]
4. Correlation of heterogeneity for chromosome 3 copy number with cell type in choroidal melanoma of mixed-cell type.
Sandinha T; Farquharson M; McKay I; Roberts F
Invest Ophthalmol Vis Sci; 2006 Dec; 47(12):5177-80. PubMed ID: 17122100
[TBL] [Abstract][Full Text] [Related]
5. Identification of candidate tumor oncogenes by integrative molecular analysis of choroidal melanoma fine-needle aspiration biopsy specimens.
McCannel TA; Burgess BL; Rao NP; Nelson SF; Straatsma BR
Arch Ophthalmol; 2010 Sep; 128(9):1170-7. PubMed ID: 20837802
[TBL] [Abstract][Full Text] [Related]
6. Chromosomal gains and losses in ocular melanoma detected by comparative genomic hybridization in an Australian population-based study.
Vajdic CM; Hutchins AM; Kricker A; Aitken JF; Armstrong BK; Hayward NK; Armes JE
Cancer Genet Cytogenet; 2003 Jul; 144(1):12-7. PubMed ID: 12810250
[TBL] [Abstract][Full Text] [Related]
7. Chromosomal gains and losses in uveal melanomas detected by comparative genomic hybridization.
Speicher MR; Prescher G; du Manoir S; Jauch A; Horsthemke B; Bornfeld N; Becher R; Cremer T
Cancer Res; 1994 Jul; 54(14):3817-23. PubMed ID: 8033101
[TBL] [Abstract][Full Text] [Related]
8. Molecular cytogenetic analysis of archival uveal melanoma with known clinical outcome.
Mensink HW; Kiliç E; Vaarwater J; Douben H; Paridaens D; de Klein A
Cancer Genet Cytogenet; 2008 Mar; 181(2):108-11. PubMed ID: 18295662
[TBL] [Abstract][Full Text] [Related]
9. Characteristic pattern of chromosomal gains and losses in marginal zone B cell lymphoma detected by comparative genomic hybridization.
Dierlamm J; Rosenberg C; Stul M; Pittaluga S; Wlodarska I; Michaux L; Dehaen M; Verhoef G; Thomas J; de Kelver W; Bakker-Schut T; Cassiman JJ; Raap AK; De Wolf-Peeters C; Van den Berghe H; Hagemeijer A
Leukemia; 1997 May; 11(5):747-58. PubMed ID: 9180302
[TBL] [Abstract][Full Text] [Related]
10. Characterization of complex chromosomal abnormalities in uveal melanoma by fluorescence in situ hybridization, spectral karyotyping, and comparative genomic hybridization.
Naus NC; van Drunen E; de Klein A; Luyten GP; Paridaens DA; Alers JC; Ksander BR; Beverloo HB; Slater RM
Genes Chromosomes Cancer; 2001 Mar; 30(3):267-73. PubMed ID: 11170284
[TBL] [Abstract][Full Text] [Related]
11. Analysis of chromosomal copy number changes and oncoprotein expression in primary central nervous system lymphomas: frequent loss of chromosome arm 6q.
Boonstra R; Koning A; Mastik M; van den Berg A; Poppema S
Virchows Arch; 2003 Aug; 443(2):164-9. PubMed ID: 12802586
[TBL] [Abstract][Full Text] [Related]
12. Regional deletion and amplification on chromosome 6 in a uveal melanoma case without abnormalities on chromosomes 1p, 3 and 8.
van Gils W; Kilic E; Brüggenwirth HT; Vaarwater J; Verbiest MM; Beverloo B; van Til-Berg ME; Paridaens D; Luyten GP; de Klein A
Melanoma Res; 2008 Feb; 18(1):10-5. PubMed ID: 18227702
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in uveal malignant melanomas.
Jay V; Yi Q; Hunter WS; Zielenska M
Pathology; 1996 Nov; 28(4):306-8. PubMed ID: 9007946
[TBL] [Abstract][Full Text] [Related]
14. Molecular cytogenetic analysis of Spitz nevi shows clear differences to melanoma.
Bastian BC; Wesselmann U; Pinkel D; Leboit PE
J Invest Dermatol; 1999 Dec; 113(6):1065-9. PubMed ID: 10594753
[TBL] [Abstract][Full Text] [Related]
15. High-density genome array is superior to fluorescence in-situ hybridization analysis of monosomy 3 in choroidal melanoma fine needle aspiration biopsy.
Young TA; Burgess BL; Rao NP; Gorin MB; Straatsma BR
Mol Vis; 2007 Dec; 13():2328-33. PubMed ID: 18199974
[TBL] [Abstract][Full Text] [Related]
16. Genomic alterations in primary cutaneous melanomas detected by metaphase comparative genomic hybridization with laser capture or manual microdissection: 6p gains may predict poor outcome.
Namiki T; Yanagawa S; Izumo T; Ishikawa M; Tachibana M; Kawakami Y; Yokozeki H; Nishioka K; Kaneko Y
Cancer Genet Cytogenet; 2005 Feb; 157(1):1-11. PubMed ID: 15676140
[TBL] [Abstract][Full Text] [Related]
17. Chromosomal imbalances in primary and metastatic melanomas: over-representation of essential telomerase genes.
Pirker C; Holzmann K; Spiegl-Kreinecker S; Elbling L; Thallinger C; Pehamberger H; Micksche M; Berger W
Melanoma Res; 2003 Oct; 13(5):483-92. PubMed ID: 14512790
[TBL] [Abstract][Full Text] [Related]
18. Concomitant loss of chromosome 3 and whole arm losses and gains of chromosome 1, 6, or 8 in metastasizing primary uveal melanoma.
Aalto Y; Eriksson L; Seregard S; Larsson O; Knuutila S
Invest Ophthalmol Vis Sci; 2001 Feb; 42(2):313-7. PubMed ID: 11157859
[TBL] [Abstract][Full Text] [Related]
19. Alterations in p16 and p53 genes and chromosomal findings in patients with lung cancer: fluorescence in situ hybridization and cytogenetic studies.
Demirhan O; Taştemir D; Hastürk S; Kuleci S; Hanta I
Cancer Epidemiol; 2010 Aug; 34(4):472-7. PubMed ID: 20444664
[TBL] [Abstract][Full Text] [Related]
20. Chromosomal gains and losses in primary colorectal carcinomas detected by CGH and their associations with tumour DNA ploidy, genotypes and phenotypes.
De Angelis PM; Clausen OP; Schjølberg A; Stokke T
Br J Cancer; 1999 May; 80(3-4):526-35. PubMed ID: 10408863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
